Table of Content


Introduction
Non Alcoholic Fatty Liver Disease (FLD) - Overview
Non Alcoholic Fatty Liver Disease (FLD) - Therapeutics Development
Non Alcoholic Fatty Liver Disease (FLD) - Therapeutics Assessment
Non Alcoholic Fatty Liver Disease (FLD) - Companies Involved in Therapeutics Development
Non Alcoholic Fatty Liver Disease (FLD) - Drug Profiles
Non Alcoholic Fatty Liver Disease (FLD) - Dormant Projects
Non Alcoholic Fatty Liver Disease (FLD) - Discontinued Products
Non Alcoholic Fatty Liver Disease (FLD) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Non Alcoholic Fatty Liver Disease (NAFLD), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Non Alcoholic Fatty Liver Disease (NAFLD), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..2), H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..3), H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Companies, H2 2020 (Contd..2), H2 2020
Products under Development by Companies, H2 2020 (Contd..3), H2 2020
Products under Development by Companies, H2 2020 (Contd..4), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Target, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Target, H2 2020 (Contd..2), H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020 (Contd..2), H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by 89bio Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by ABIONYX Pharma SA, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Afimmune Biopharma Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Albireo Pharma Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Amicogen Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by AptamiR Therapeutics Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by AstraZeneca Plc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Azure Health Technology Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by BBN Cardio Therapeutics, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Beijing Fogangren Bio-Pharm Tech Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Betagenon AB, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Bird Rock Bio Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Cadila Healthcare Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Can-Fite BioPharma Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Carmot Therapeutics Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by ChemomAb Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by China NT Pharma Group Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Corbus Pharmaceuticals Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Corcept Therapeutics Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Curacle Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Dr. Falk Pharma GmbH, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by DURECT Corp, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Eli Lilly and Co, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Eternygen GmbH, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Evgen Pharma Plc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by F. Hoffmann-La Roche Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Fujian Cosunter Pharmaceutical Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Galmed Pharmaceuticals Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by GemVax & KAEL Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Gilead Sciences Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Hepion Pharmaceuticals Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by HK inno.N Corp, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Huons Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Immuron Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Inorbit Therapeutics AB, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Inventiva, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Ionis Pharmaceuticals Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by J2H Biotech, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Kinomedica Pty Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by KoBioLabs Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Kowa Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Liminal BioSciences Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Lynkogen Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Macrophage Pharma Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Macrophage Therapeutics Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Mallinckrodt Plc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Metacrine Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Micelle BioPharma Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Mina Therapeutics Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Nano Intelligent Biomedical Engineering Corp, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by NeuroBo Pharmaceuticals Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by NGM Biopharmaceuticals Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Nivarta Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Novartis AG, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by NovMetaPharma Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by NuSirt Biopharma Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Oncocross Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by PegBio Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Pfizer Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by PharmaKing Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Phenex Pharmaceuticals AG, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by PTC Therapeutics Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Renova Therapeutics Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Salix Pharmaceuticals Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Shenzhen HighTide Biopharmaceutical Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by SparkBioPharma Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Sveikatal Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by T3D Therapeutics Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by TaiwanJ Pharmaceuticals Co Ltd, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Terns Pharmaceuticals Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by TES Pharma SRL, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Theratechnologies Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Vidasym Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Viking Therapeutics Inc, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Dormant Projects, H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Dormant Projects, H2 2020 (Contd..1), H2 2020
Non Alcoholic Fatty Liver Disease (NAFLD) - Discontinued Products, H2 2020